THOUSAND OAKS, Calif.--(BUSINESS WIRE)--April 4, 2005--Amgen Inc. (Nasdaq:AMGN), the world's largest biotechnology company, today announced that it plans to report its first quarter financial results on Thursday, April 21, 2005 after the close of the financial markets. The announcement will be followed by a conference call with the investment community at 2 p.m. Pacific Daylight Time.
Participating in the call from Amgen will be Kevin Sharer, chairman and chief executive officer, and other members of Amgen's senior management team.
Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public. The conference call, including the question and answer session, is expected to last approximately one hour.
The webcast of the conference can be found on Amgen's Web site, www.amgen.com, by clicking on Investors. A link to the webcast is under the Events header. The webcast will be archived and available for replay 72 hours after the event.
Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.
CONTACT: Amgen, Thousand Oaks
Christine Cassiano, 805-447-4587 (media)
Arvind Sood, 805-447-1060 (investors)
SOURCE: Amgen Inc.